• OPEN AN ACCOUNT
Indian Indices
Sensex
75,692.78 1,233.25
( 1.66%)
Global Indices
Nasdaq
51,732.40 -631.16
(-1.21%)
Dow Jones
7,581.68 -159.71
(-2.06%)
Hang Seng
63,112.86 -177.25
(-0.28%)
Nikkei 225
10,768.78 39.00
(0.36%)
Forex
USD-INR
95.22 0.06
(0.06%)
EUR-INR
106.19 0.24
(0.23%)
GBP-INR
127.01 0.44
(0.35%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

FDC Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
531599
INE258B01022
164.1526706
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
FDC
18.63
6132.24
EPS(TTM)
Face Value()
Div & Yield %
20.22
1
1.33
 

corpus ltd
Procter & Gamble Health standalone net profit rises 54.63% in the March 2026 quarter
May 27,2026
Net profit of Procter & Gamble Health rose 54.63% to Rs 94.60 crore in the quarter ended March 2026 as against Rs 61.18 crore during the previous quarter ended March 2025. Sales rose 19.12% to Rs 370.45 crore in the quarter ended March 2026 as against Rs 310.99 crore during the previous quarter ended March 2025.

For the full year,net profit rose 39.46% to Rs 326.91 crore in the year ended March 2026 as against Rs 234.41 crore during the previous year ended March 2025. Sales rose 50.72% to Rs 1407.97 crore in the year ended March 2026 as against Rs 934.17 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales370.45310.99 19 1407.97934.17 51
OPM %36.6026.02 -32.4334.08 -
PBDT139.3883.90 66 473.45328.31 44
PBT133.2178.53 70 449.86311.62 44
NP94.6061.18 55 326.91234.41 39